Stability of valganciclovir in extemporaneously compounded liquid formulationsHENKIN, Carolyn C; GRIENER, James C; TEN EICK, Andrew P et al.American journal of health-system pharmacy. 2003, Vol 60, Num 7, pp 687-690, issn 1079-2082, 4 p.Article

A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipientsHUMAR, Atul; SIEGAL, Deborah; MOUSSA, George et al.The Journal of infectious diseases. 2005, Vol 192, Num 7, pp 1154-1157, issn 0022-1899, 4 p.Article

Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovirMATTES, F. M; HAINSWORTH, E. G; HASSAN-WALKER, A. F et al.The Journal of infectious diseases. 2005, Vol 191, Num 1, pp 89-92, issn 0022-1899, 4 p.Article

Cytomegalovirus pneumonia in immunocompetent host: Case report and literature reviewGRILLI, Elisabetta; GALATI, Vincenzo; BORDI, Licia et al.Journal of clinical virology. 2012, Vol 55, Num 4, pp 356-359, issn 1386-6532, 4 p.Article

Cytomegalovirus Prophylaxis in Solid Organ Transplantation : Prophylactic Treatment with Antiviral Agents ro Prevent Infection and DiseaseALEXOPOULOS, S. P; LINDBERG, L; SUBRAMANYAN, R. K et al.Current medicinal chemistry. 2012, Vol 19, Num 35, pp 5957-5963, issn 0929-8673, 7 p.Article

Effect on Hearing of Oral Valganciclovir for Asymptomatic Congenital Cytomegalovirus InfectionCIFTDOGAN, Dilek Yilmaz; VARDAR, Fadil.Journal of tropical pediatrics (1980). 2011, Vol 57, Num 2, pp 132-134, issn 0142-6338, 3 p.Article

Human herpesvirus 6 meningoradiculitis treated with intravenous immunoglobulin and valganciclovirKARAM, Chafic; REVUELTA, Manuel; MACGOWAN, Daniel et al.Journal of neurovirology. 2009, Vol 15, Num 1, pp 108-109, issn 1355-0284, 2 p.Article

Successful oral valganciclovir treatment of cytomegalovirus infection during Campath-1H therapyGONZALEZ, H; VERNANT, J. P; CAUMES, E et al.Leukemia. 2005, Vol 19, Num 3, issn 0887-6924, p. 478Article

Cardiologie : Préférer les résultats cliniques aux critères intermédiaires = Cardiology: clinical results better than intermediate criterionsLa Revue Prescrire. 2005, Vol 25, Num 257, pp 30-32, issn 0247-7750, 3 p.Article

Stability of valganciclovir in an extemporaneously compounded oral liquidANAIZI, Nasr H; DENTINGER, Paul J; SWENSON, Chad F et al.American journal of health-system pharmacy. 2002, Vol 59, Num 13, pp 1267-1270, issn 1079-2082Article

Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxisBOIVIN, Guy; GOYETTE, Nathalie; FARHAN, Mahdi et al.Journal of clinical virology. 2012, Vol 53, Num 3, pp 208-213, issn 1386-6532, 6 p.Article

Unexpectedly high inter-and intrapatient variability of Ganciclovir levels in childrenVETHAMUTHU, Jennifer; FEBER, Janusz; CHRETIEN, Ann et al.Pediatric transplantation. 2007, Vol 11, Num 3, pp 301-305, issn 1397-3142, 5 p.Article

Reactivity of valganciclovir in aqueous solutionSTEFANIDIS, Dimitrios; BRANDL, Michael.Drug development and industrial pharmacy. 2005, Vol 31, Num 9, pp 879-884, issn 0363-9045, 6 p.Article

Cytomegalovirus Prophylaxis with Valganciclovir in Cytomegalovirus-Seropositive Kidney-Transplant PatientsWECLAWIAK, Hugo; KAMAR, Nassim; MENGELLE, Catherine et al.Journal of medical virology. 2008, Vol 80, Num 7, pp 1228-1232, issn 0146-6615, 5 p.Article

Viral-Associated Trichodysplasia of Immunosuppression: Report of a Pediatric Patient With Response to Oral ValganciclovirBENOIT, Taylor; BACELIERI, Rocky; MORRELL, Dean S et al.Archives of dermatology (1960). 2010, Vol 146, Num 8, pp 871-874, issn 0003-987X, 4 p.Article

Protease-mediated preparation of valganciclovir intermediateSETHI, Madhuresh K; BHANDYA, Somashekar R; SHUKLA, Rohit et al.Journal of molecular catalysis. B, Enzymatic. 2014, Vol 108, pp 77-81, issn 1381-1177, 5 p.Article

Valganciclovir for treatment of congenital cytomegalovirus infectionSCHULZKE, Sven; BUHRER, Christoph.European journal of pediatrics. 2006, Vol 165, Num 8, pp 575-576, issn 0340-6199, 2 p.Article

Treatment of symptomatic congenital cytomegalovirus infection with valganciclovirMEINE JANSEN, Caroline F; TOET, Mona C; RADEMAKER, Carin M. A et al.Journal of perinatal medicine. 2005, Vol 33, Num 4, pp 364-366, issn 0300-5577, 3 p.Article

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantationAYALA, E; GREENE, J; SANDIN, R et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 9, pp 851-856, issn 0268-3369, 6 p.Article

Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant RecipientsCHAMBERLAIN, C. E; PENZAK, S. R; ALFARO, R. M et al.American journal of transplantation (Print). 2008, Vol 8, Num 6, pp 1297-1302, issn 1600-6135, 6 p.Article

Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral ValganciclovirPERROTTET, N; CSAJKA, C; BIOLLAZ, J et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 3017-3023, issn 0066-4804, 7 p.Article

Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipientsWILTSHIRE, Hugh; PAYA, Carlos V; ZUIDEVELD, Klaas P et al.Transplantation. 2005, Vol 79, Num 11, pp 1477-1483, issn 0041-1337, 7 p.Article

Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal periodDEL ROSAL, Teresa; BAQUERO-ARTIGAO, Fernando; BLAZQUEZ, Daniel et al.Journal of clinical virology. 2012, Vol 55, Num 1, pp 72-74, issn 1386-6532, 3 p.Article

Valganciclovir for congenital CMV infection : A pilot study on plasma concentration in newborns and infantsGALLI, Luisa; NOVELLI, Andrea; CHIAPPINI, Elena et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 5, pp 451-453, issn 0891-3668, 3 p.Article

Valganciclovir for Suppression of Human Herpesvirus-8 Replication : A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. CommentaryCRUMPACKER, Clyde S; CASPER, Corey; KRANTZ, Elizabeth M et al.The Journal of infectious diseases. 2008, Vol 198, Num 1, issn 0022-1899, 6-7, 23-30 [10 p.]Article